Identified 30 cases of collisions between evacuees with AstraZeneca in United Kingdom | Salud | La Revista

The British regulators have identified 30 cases of rare blood clots between people evacuated with AstraZeneca in the United Kingdom, but have recalled the benefits of its preparation to combat covid-19.

The Health and Medical Care Regulatory Agency (MHRA, in English) has insisted that the risks associated with these coagulants are “very small” and that the population must accept the vaccine provided by Health Care.

These cases have been observed among the 18.1 million people who received this vaccine in the United Kingdom until the final of March.

Of the 30 incidents, 22 correspond to venous cerebral thrombi (CVST, for its English seals) and also to other problems related to the coagulation of blood with plaque.

Adam Finn, Integrator of the Joint Committee on Vacation and Immunization (JCVI, in English) – a cargo of the plan of vacation of the country, signal that it is prepared, “of lies, the most secure option to reduce pregnancy risks o morir a causa de la covid-19 ”.

Finn, of the English University of Bristol, explains that this is the media that these cases are “very carefully researched to get better” and has some type of “casual angle with the vacation”.

“However, the extreme rarity of these cases in the context of many millions of doses that he has administered means that the decision about the risk or benefit that the person faces when he is invited to receive the vaccine against covid-19 is dead : get the vacuna es, de lejos, the most secure option ”.

The regulators have made it clear that they have not received notification of clogging problems in the vacancies with the BioNTech / Pfizer product.

This information is based on the rumor that Germany has decided to suspend the use of AstraZeneca for people under 60 years of age prior to the death of a possible corner with bullets.

Thus, the European Medicines Agency (EMA) indicated that it had “no evidence” to restrict the use of the AstraZeneca vaccine among the population.

In addition to this preparation, the United Kingdom is vacant with the Pfizer and more than 30 million people have received at least the first of these doses of vacancies. (I)